WuXi XDC acquired the conjugation space.
Published
Signal category
Strategy & Corporate Development
Quote
“WuXi XDC would acquire us”
— Oscar Hoogteijling|WuXi XDC team
Company
WuXi XDC
Your single-source ADC/Bioconjugate discovery, development and manufacturing solution
- Industry
- Pharmaceutical Manufacturing
- Company size
- 337 employees
WuXi XDC is a leading CRDMO focused on the global ADC and broader bioconjugate market and is dedicated to providing integrated services from concept development to commercialization. All services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities, providing high efficiency and significant reduction of development timeline and costs. Our community of over 1000 skilled employees work across a global network to provide an open-access platform with the most comprehensive capabilities and technologies. WuXi XDC enables its biopharmaceutical partners to innovate, accelerate, and transform the development of the bioconjugate industry, to the benefit of patients worldwide.
Founded 2021